BRIEF-Ipsen and Telesta Therapeutics announce exclusive license agreement for MCNA1
October 28, 2015 at 02:20 AM EDT
* Telesta Therapeutics and Ipsen announce exclusive license agreement for MCNA1 for the treatment of non-muscle invasive bladder cancer in major ex-United States territories
